Literature DB >> 23640626

Screening for chronic kidney diseases among an adult population.

Kaniz Fatema1, Zainal Abedin, Abul Mansur, Farzana Rahman, Taslima Khatun, Nurunnahar Sumi, Khadizatul Kobura, Selima Akter, Liaquat Ali.   

Abstract

Chronic kidney disease (CKD) is now one of the major health problems all over the world and its early screening is vital to prevent the development of end-stage renal failure. This study was designed to evaluate the proportion of urban adults suffering from CKD as well as to have a preliminary idea about the determinants of this disorder. The screening program for CKD was arranged in a public place in Dhaka city, Bangladesh, and involved 634 adult participants (>18 years of age) selected on first-come first-served basis. Socio-demographic, anthropometric, and clinical data were collected. Urinary protein was tested by the dipstick method, and serum glucose and creatinine were measured by an auto-analyzer. Estimated glomerular filtrate rate (eGFR) was calculated by using standard formula. CKD was diagnosed and classified according to the National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines. A total of 12.8% of the subjects were found to have CKD of whom 2.7% were in Stage 1, 4.1% in Stage 2, and 6% were in Stage 3. The proportion was strongly influenced by age, with the highest prevalence (38.5%) found at 60 years and above. The CKD group showed higher body mass index, waist-hip ratio, and systolic blood pressure, compared with their non-CKD counterparts (P = 0.02). On multiple regression analysis (after adjustment of some confounding variables), age, random blood sugar, and education showed significant association with the development of CKD. A substantial number of urban adults in Dhaka were found to be unaware about the existence of CKD and large-scale prevention programs should be undertaken to reduce the classical risk factors of these disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640626     DOI: 10.4103/1319-2442.111049

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  6 in total

1.  Renal insufficiency among urban populations in Bangladesh: A decade of laboratory-based observations.

Authors:  Sumon Kumar Das; Syeda Momena Afsana; Shahriar Bin Elahi; Mohammod Jobayer Chisti; Jui Das; Abdullah Al Mamun; Harold David McIntyre; Tahmeed Ahmed; Abu Syed Golam Faruque; Mohammed Abdus Salam
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

2.  Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh.

Authors:  Mohammad Habibur Rahman Sarker; Michiko Moriyama; Harun Ur Rashid; Mohammod Jobayer Chisti; Md Moshiur Rahman; Sumon Kumar Das; Aftab Uddin; Samir Kumar Saha; Shams El Arifeen; Tahmeed Ahmed; Asg Faruque
Journal:  Ther Adv Chronic Dis       Date:  2021-07-31       Impact factor: 5.091

3.  Factors Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes in Bangladesh.

Authors:  Sheikh Mohammed Shariful Islam; Masudus Salehin; Sojib Bin Zaman; Tania Tansi; Rajat Das Gupta; Lingkan Barua; Palash Chandra Banik; Riaz Uddin
Journal:  Int J Environ Res Public Health       Date:  2021-11-23       Impact factor: 3.390

4.  Comparative Analysis for Prediction of Kidney Disease Using Intelligent Machine Learning Methods.

Authors:  Gazi Mohammed Ifraz; Muhammad Hasnath Rashid; Tahia Tazin; Sami Bourouis; Mohammad Monirujjaman Khan
Journal:  Comput Math Methods Med       Date:  2021-12-03       Impact factor: 2.238

5.  Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure.

Authors:  Yu-Hsuan Peng; Douglas H Sweet; Shiuan-Pey Lin; Chung-Ping Yu; Pei-Dawn Lee Chao; Yu-Chi Hou
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

6.  Prevalence of chronic kidney disease in South Asia: a systematic review.

Authors:  Mehedi Hasan; Ipsita Sutradhar; Rajat Das Gupta; Malabika Sarker
Journal:  BMC Nephrol       Date:  2018-10-23       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.